A detailed history of Nine Masts Capital LTD transactions in Legend Biotech Corp stock. As of the latest transaction made, Nine Masts Capital LTD holds 13,609 shares of LEGN stock, worth $535,514. This represents 0.2% of its overall portfolio holdings.

Number of Shares
13,609
Holding current value
$535,514
% of portfolio
0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$43.55 - $59.88 $592,671 - $814,906
13,609 New
13,609 $663,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.59B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Nine Masts Capital LTD Portfolio

Follow Nine Masts Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nine Masts Capital LTD with notifications on news.